1 All‐cause mortality |
16 |
7708 |
Odds Ratio (M‐H, Fixed, 95% CI) |
1.86 [0.75, 4.60] |
1.1 IND/GLY 110/50 |
3 |
976 |
Odds Ratio (M‐H, Fixed, 95% CI) |
2.97 [0.47, 18.97] |
1.2 UMEC/VI 62.5/25 |
5 |
1921 |
Odds Ratio (M‐H, Fixed, 95% CI) |
3.12 [0.68, 14.36] |
1.3 UMEC/VI 125/25 |
4 |
1401 |
Odds Ratio (M‐H, Fixed, 95% CI) |
0.14 [0.01, 2.83] |
1.4 UMEC/VI 500/25 |
1 |
51 |
Odds Ratio (M‐H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
1.5 TIO/OLO 2.5/5 |
6 |
1670 |
Odds Ratio (M‐H, Fixed, 95% CI) |
2.53 [0.12, 53.43] |
1.6 TIO/OLO 5/5 |
6 |
1689 |
Odds Ratio (M‐H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
2 SAEs |
19 |
8682 |
Odds Ratio (M‐H, Fixed, 95% CI) |
1.02 [0.80, 1.29] |
2.1 IND/GLY 110/50 |
3 |
976 |
Odds Ratio (M‐H, Fixed, 95% CI) |
1.35 [0.54, 3.40] |
2.2 UMEC/VI 62.5/25 |
6 |
2317 |
Odds Ratio (M‐H, Fixed, 95% CI) |
1.29 [0.86, 1.93] |
2.3 UMEC/VI 125/25 |
4 |
1403 |
Odds Ratio (M‐H, Fixed, 95% CI) |
0.75 [0.46, 1.22] |
2.4 UMEC/VI 500/25 |
1 |
51 |
Odds Ratio (M‐H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
2.5 TIO/OLO 2.5/5 |
6 |
1670 |
Odds Ratio (M‐H, Fixed, 95% CI) |
0.90 [0.49, 1.68] |
2.6 TIO/OLO 5/5 |
7 |
1840 |
Odds Ratio (M‐H, Fixed, 95% CI) |
0.97 [0.55, 1.73] |
2.7 ACM/FOR 200/6 |
1 |
141 |
Odds Ratio (M‐H, Fixed, 95% CI) |
0.51 [0.02, 12.96] |
2.8 ACM/FOR 200/12 |
1 |
140 |
Odds Ratio (M‐H, Fixed, 95% CI) |
0.51 [0.02, 13.07] |
2.9 ACM/FOR 200/18 |
1 |
144 |
Odds Ratio (M‐H, Fixed, 95% CI) |
1.11 [0.06, 22.41] |
3 AECOPD |
3 |
1127 |
Odds Ratio (M‐H, Fixed, 95% CI) |
0.53 [0.36, 0.78] |
3.1 UMEC/VI 62.5/25 |
2 |
786 |
Odds Ratio (M‐H, Fixed, 95% CI) |
0.58 [0.37, 0.93] |
3.2 UMEC/VI 125/25 |
1 |
290 |
Odds Ratio (M‐H, Fixed, 95% CI) |
0.37 [0.17, 0.78] |
3.3 UMEC/VI 500/25 |
1 |
51 |
Odds Ratio (M‐H, Fixed, 95% CI) |
1.68 [0.08, 35.43] |
4 Time to first AECOPD |
2 |
|
Hazard Ratio (Fixed, 95% CI) |
0.44 [0.31, 0.63] |
4.1 UMEC/VI 125/25 |
2 |
|
Hazard Ratio (Fixed, 95% CI) |
0.44 [0.31, 0.63] |
5 Difference vs placebo in adjusted SGRQ score (HRQoL) |
6 |
|
Mean Difference (Fixed, 95% CI) |
‐4.15 [‐4.99, ‐3.32] |
5.1 UMEC/VI 62.5/25 |
3 |
|
Mean Difference (Fixed, 95% CI) |
‐4.25 [‐5.73, ‐2.77] |
5.2 UMEC/VI 125/25 |
2 |
|
Mean Difference (Fixed, 95% CI) |
‐3.64 [‐5.48, ‐1.80] |
5.3 TIO/OLO 2.5/5 |
2 |
|
Mean Difference (Fixed, 95% CI) |
‐3.89 [‐5.60, ‐2.17] |
5.4 TIO/OLO 5/5 |
2 |
|
Mean Difference (Fixed, 95% CI) |
‐4.72 [‐6.43, ‐3.01] |
6 SGRQ responder analysis |
6 |
3552 |
Odds Ratio (M‐H, Fixed, 95% CI) |
1.84 [1.59, 2.12] |
6.1 TIO/OLO 2.5/5 |
2 |
579 |
Odds Ratio (M‐H, Fixed, 95% CI) |
1.87 [1.30, 2.70] |
6.2 TIO/OLO 5/5 |
2 |
578 |
Odds Ratio (M‐H, Fixed, 95% CI) |
2.35 [1.63, 3.40] |
6.3 UMEC/VI 62.5/25 |
3 |
1441 |
Odds Ratio (M‐H, Fixed, 95% CI) |
1.70 [1.37, 2.12] |
6.4 UMEC/VI 125/25 |
2 |
954 |
Odds Ratio (M‐H, Fixed, 95% CI) |
1.78 [1.35, 2.34] |